文献速递心脏核医学

定量血流比衍生的回撤压力梯度与CZT-SPECT测量的纵向血流梯度用于评估血流动力学显著的冠状动脉疾病

Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease.
PubMed 文献 · J Nucl Cardiol · 2023-03-16

本研究探讨定量血流比(QFR)回撤压力梯度(PPG)与99mTc-MIBI CZT-SPECT测量的纵向心肌血流量(MBF)梯度是否相关,并评估其对心肌缺血的诊断性能。结果显示QFR-PPG与充血性纵向MBF梯度(r=0.45,P=0.007)及Δ纵向MBF梯度(r=0.41,P=0.016)显著相关;QFR-PPG、充血性纵向MBF梯度和Δ纵向MBF梯度对预测RFR降低或QFR降低的诊断性能相当(AUC比较P=NS);QFR-PPG联合QFR较单用QFR对预测RFR有增量价值(AUC=0.83 vs 0.73,P=0.046,净重分类指数=0.508,P=0.001)。

要点

  • QFR-PPG与充血性纵向MBF梯度(r=0.45,P=0.007)及Δ纵向MBF梯度(r=0.41,P=0.016)显著相关。
  • RFR较低血管的QFR-PPG(0.72 vs 0.82,P=0.002)、充血性纵向MBF梯度(1.14 vs 2.22,P=0.003)和Δ纵向MBF梯度(0.50 vs 1.02,P=0.003)均较低。
  • QFR-PPG联合QFR较单用QFR预测RFR的AUC为0.83 vs 0.73(P=0.046),净重分类指数=0.508(P=0.001)。

核心结论

  • QFR-PPG与纵向MBF梯度及Δ纵向MBF梯度显著相关,可用于评估冠状动脉生理性弥漫性病变。
  • QFR-PPG、充血性纵向MBF梯度和Δ纵向MBF梯度三者对预测RFR或QFR具有较高准确性。
  • 加入生理性弥漫性评估可提高预测心肌缺血的准确性。

研究设计与样本

  • 本研究测量了静息和负荷状态下99mTc-MIBI CZT-SPECT的MBF(单位mL g-1 min-1),并计算MFR(MBF负荷/MBF静息)和RFR(狭窄区MBF/参考区MBF)。
  • 纵向MBF梯度定义为左心室心尖与基底部的MBF梯度,Δ纵向MBF梯度由负荷与静息纵向MBF梯度计算得出。
  • QFR-PPG从虚拟QFR回撤曲线获取。

主要发现

  • QFR-PPG与充血性纵向MBF梯度显著相关(r=0.45,P=0.007),与Δ纵向MBF梯度(负荷-静息)显著相关(r=0.41,P=0.016)。
  • RFR较低血管的QFR-PPG为0.72 vs 0.82(P=0.002),充血性纵向MBF梯度为1.14 vs 2.22(P=0.003),Δ纵向MBF梯度为0.50 vs 1.02(P=0.003)。
  • QFR-PPG、充血性纵向MBF梯度和Δ纵向MBF梯度对预测RFR降低的AUC分别为0.82、0.81、0.75(P=NS),对预测QFR降低的AUC分别为0.83、0.72、0.80(P=NS)。
  • QFR-PPG联合QFR较单用QFR预测RFR的AUC为0.83 vs 0.73(P=0.046),净重分类指数=0.508(P=0.001)。

关键数值与推荐

  • QFR-PPG与充血性纵向MBF梯度相关系数r=0.45(P=0.007),与Δ纵向MBF梯度相关系数r=0.41(P=0.016)。
  • RFR较低血管QFR-PPG 0.72 vs RFR较高血管0.82(P=0.002);充血性纵向MBF梯度1.14 vs 2.22(P=0.003);Δ纵向MBF梯度0.50 vs 1.02(P=0.003)。
  • 预测RFR降低的AUC:QFR-PPG 0.82 vs 充血性纵向MBF梯度0.81 vs Δ纵向MBF梯度0.75(P=NS)。
  • 预测QFR降低的AUC:QFR-PPG 0.83 vs 充血性纵向MBF梯度0.72 vs Δ纵向MBF梯度0.80(P=NS)。
  • QFR-PPG联合QFR vs 单用QFR预测RFR的AUC=0.83 vs 0.73(P=0.046),净重分类指数=0.508(P=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether physiological coronary diffuseness assessed by quantitative flow reserve (QFR) pullback pressure gradient (PPG) correlates with longitudinal myocardial blood flow (MBF) gradient and improves diagnostic performances for myocardial ischemia remains unknown. METHODS AND RESULTS: MBF was measured in mL g-1 min-1 with 99mTc-MIBI CZT-SPECT at rest and stress, corresponding myocardial flow reserve (MFR = MBF stress/MBF rest) and relative flow reserve (RFR = MBF stenotic area/MBF reference) were calculated. Longitudinal MBF gradient was defined as apical and basal left ventricle MBF gradient. △longitudinal MBF gradient was calculated by longitudinal MBF gradient at stress and rest. QFR-PPG was acquired from virtual QFR pullback curve. QFR-PPG significantly correlated with hyperemic longitudinal MBF gradient (r = 0.45, P = 0.007) and △longitudinal MBF gradient (stress-rest) (r = 0.41, P = 0.016). Vessels with lower RFR had lower QFR-PPG (0.72 vs. 0.82, P = 0.002), hyperemic longitudinal MBF gradient (1.14 vs. 2.22, P = 0.003) and △longitudinal MBF gradient (0.50 vs. 1.02, P = 0.003). QFR-PPG, hyperemic longitudinal MBF gradient and △longitudinal MBF gradient showed comparable diagnostic performances for predicting decreased RFR (area under curve [AUC]: 0.82 vs. 0.81 vs. 0.75, P = NS) or QFR (AUC: 0.83 vs. 0.72 vs. 0.80, P = NS). In addition, QFR-PPG and QFR in combination showed incremental value compared with QFR for predicting RFR (AUC = 0.83 vs. 0.73, P = 0.046, net reclassification index = 0.508, P = 0.001). CONCLUSION: QFR-PPG significantly correlated with longitudinal MBF gradient and △longitudinal MBF gradient when used for physiological coronary diffuseness assessment. All three parameters had high accuracy in predicting RFR or QFR. Adding physiological diffuseness assessment increased accuracy for predicting myocardial ischemia.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Dai N, Zhang B, Gong Z, et al. Quantitative flow ratio derived pullback pressure gradient and CZT-SPECT measured longitudinal flow gradient for hemodynamically significant coronary artery disease. J Nucl Cardiol. 2023. PMID: 36929292. doi:10.1007/s12350-023-03245-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。